QFT — Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder Class II

FDA Device Classification

FDA product code QFT covers "Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder", a Class II medical device regulated under 21 CFR 882.5803. Submissions are reviewed by the Obstetrics/Gynecology panel. At least 4 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
QFT
Device Class
Class II
Regulation Number
882.5803
Submission Type
Review Panel
NE
Medical Specialty
Obstetrics/Gynecology
Implant
No

Definition

A digital therapy device for Attention Deficit Hyperactivity Disorder (ADHD) is a software intended to provide therapy for ADHD or any of its individual symptoms as an adjunct to clinician supervised treatment.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K243729lumos labsPrismiraJune 13, 2025
K233496akili interactive labsEndeavorOTCJune 14, 2024
K231337akili interactive labsEndeavorRxDecember 13, 2023
DEN200026akili interactive labsEndeavorRxJune 15, 2020